For example, breast cancer cells carrying mutations of the BRCA2 gene are deficient in the HR repair pathway and are consequently particularly sensitive to chemical inhibitors of alternative DNA repair pathways [47]. This evidence concerns the gene BRCA2 and breast cancer.